Business Standard

After Sputnik-V, Russia to register second Covid-19 vaccine by Oct 15

Russia registered its first vaccine candidate, developed by Moscow's Gamaleya Institute, in August.

Covid-19 coronavirus
Premium

The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.

Reuters Moscow
Russia expects to register a second potential vaccine against Covid-19 by October 15, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Tuesday.
 
 The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.
 
 Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August.
 
Late-stage trials, involving at least 40,000 people, are ongoing.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in